Citigroup Maintains Buy on DexCom, Raises Price Target to $150
Portfolio Pulse from richadhand@benzinga.com
Citigroup analyst Joanne Wuensch maintains a Buy rating on DexCom (NASDAQ:DXCM) and raises the price target from $146 to $150.
July 11, 2023 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup maintains a Buy rating on DexCom and raises the price target from $146 to $150, which could lead to a positive impact on the stock.
The raised price target by Citigroup indicates a positive outlook for DexCom. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100